Last month, the European Medicines Agency allowed Novo to add risk reduction for events related to kidney disease to the ...
A multicenter collaboration has identified a potential new treatment for an aggressive sarcoma arising in the nerves. The ...
FDA formally announced the end of the tirzepatide shortage in a Declaratory Order issued to Eli Lilly & Co. (“Lilly”). Lilly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback